Protabit is at the forefront of computational protein design, offering a modern, open database known as ProtaBank, which serves as a comprehensive repository for protein engineering data. This database integrates the extensive thermodynamic data from ProTherm, which includes over 25,000 entries related to protein stability. Protabit aims to standardize the reporting of mutant protein sequences and experimental assay data, facilitating easier comparisons across various datasets. The incorporation of advanced analysis and visualization tools is designed to support scientific discovery and guide future protein design efforts, ultimately enhancing the understanding of sequence-function relationships.

Additionally, Protabit is developing Triad, a web-based software platform that simplifies the protein design process for bench scientists. By leveraging cloud computing, Triad enables users to execute protein designs and create variant libraries without the need for complex installations or expensive hardware. The platform is built to be user-friendly and secure, featuring automated workflows and interactive visualization tools that make protein engineering more accessible. Protabit's commitment to innovation is further underscored by its collaborations with leading research institutions and ongoing support from the National Institutes of Health, which has provided funding to enhance the capabilities of both ProtaBank and Triad.

United States

Protabit LLC engineers proteins for industrial, agricultural, and healthcare applications. The company's platform technology is being developed via a strategic partnership with the Monsanto Company and the California Institute of Technology. Protabit's protein engineering approach combines computational modeling with high-throughput screening and directed evolution to expand the diversity of protein sequences that can be explored to produce novel proteins.

Protabit

Company Details